Nitrous oxide

Description

Nitrous oxide, USP, is a chemical compound with the CAS number 10024-97-2. It is classified as UN1070 and is characterized as a non-flammable oxidizer with a hazard classification of 5.1.

Uses and Indications

Nitrous Oxide is indicated for use in medical settings where its administration is deemed appropriate by a licensed practitioner. This drug should only be administered by or under the supervision of a healthcare professional who possesses experience in the use and administration of Nitrous Oxide. The practitioner must be knowledgeable about the drug's indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrous Oxide administration, which may render its use contraindicated in certain situations. There are no specific teratogenic or nonteratogenic effects documented for this drug.

Dosage and Administration

Nitrous Oxide is administered via inhalation for therapeutic purposes. The concentration of Nitrous Oxide is 990 mL per 1 L of the gas mixture. Healthcare professionals should ensure that the delivery system is properly calibrated to maintain the specified concentration during administration.

Inhalation should be performed in a controlled environment, with continuous monitoring of the patient’s response to the gas. It is essential to follow institutional protocols regarding the initiation and cessation of inhalation therapy, as well as to observe for any adverse reactions during the procedure.

Contraindications

Administration of Nitrous Oxide is contraindicated due to potential hazards associated with its use.

Breathing the gas is to be avoided, as it may pose significant risks. Additionally, contact with liquid Nitrous Oxide should be strictly prevented to avoid exposure to eyes, skin, or clothing, which can lead to serious injury.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent be used only by or under the supervision of a licensed practitioner who possesses expertise in the use and administration of Nitrous Oxide. This practitioner should be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrous Oxide is classified as a high-pressure oxidizing liquid gas, which vigorously accelerates combustion and can lead to rapid suffocation. The anesthetic effects of Nitrous Oxide may also pose risks, including the potential for frostbite. To mitigate these hazards, it is essential to avoid inhalation of the gas and to ensure adequate ventilation during storage and use. Equipment must be specifically cleaned for oxygen use and rated for cylinder pressure, while oil and grease must be kept away from the gas. Care should be taken to prevent liquid from contacting the eyes, skin, or clothing. The cylinder temperature must not exceed 52°C (125°F), and the valve should be opened slowly. It is crucial to close the valve after each use and when the cylinder is empty, and to utilize a backflow preventive device in the piping. All handling should be conducted in accordance with the Material Safety Data Sheet (MSDS).

In the event of inhalation, immediate action is required. The individual should be removed to fresh air, and if breathing has ceased, artificial respiration should be administered. If breathing is difficult, supplemental oxygen should be provided, and a physician should be contacted without delay. In cases of frostbite, prompt medical treatment is essential.

Side Effects

Administration of Nitrous Oxide may be hazardous or contraindicated due to its potential adverse reactions. Notably, it is classified as a high-pressure oxidizing liquid gas, which vigorously accelerates combustion and can lead to rapid suffocation. The anesthetic effects associated with Nitrous Oxide can pose significant risks, including the potential for frostbite.

Participants in clinical settings have reported anesthetic effects as a common reaction to Nitrous Oxide. Additionally, there is a risk of frostbite, which may occur if the gas is improperly handled or administered.

In the event of inhalation, it is crucial to remove the affected individual to fresh air immediately. If the individual is not breathing, artificial respiration should be administered, and if breathing difficulties arise, oxygen should be provided. It is essential to call a physician for further evaluation and management. In cases of frostbite, obtaining medical treatment promptly is imperative to mitigate potential complications.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide is not specifically detailed in the available prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for children provided in the insert. Therefore, healthcare professionals should exercise caution and consider the lack of specific pediatric data when administering Nitrous Oxide to pediatric patients.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The administration of Nitrous Oxide is contraindicated in pregnancy due to potential risks to fetal outcomes. Pregnant patients should not be exposed to Nitrous Oxide, as its use may pose hazards that could adversely affect the developing fetus. It is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who is experienced in its administration. Healthcare professionals are advised to consider alternative analgesic options for pregnant patients to ensure maternal and fetal safety.

Lactation

There are no specific warnings or recommendations regarding the use of Nitrous Oxide in lactating mothers. Additionally, there are no specific warnings or recommendations concerning the use of Nitrous Oxide during lactation. As such, healthcare professionals may consider the absence of contraindications when advising lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be warranted to guide management decisions.

It is crucial to document all findings and interventions in the patient's medical record and to report any adverse events to the appropriate regulatory authorities as required.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has revealed several adverse reactions reported voluntarily or through surveillance programs. These include gastrointestinal symptoms such as nausea and vomiting, as well as neurological effects including dizziness and headache. Additionally, there have been reports of hallucinations and respiratory depression.

Cardiovascular effects noted include hypotension and bradycardia. Furthermore, cases of increased intracranial pressure have been documented. It is important to note that frostbite injuries have been associated with improper handling of the gas.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the following warning to patients: Nitrous Oxide is a high-pressure oxidizing liquid gas that vigorously accelerates combustion, which can lead to rapid suffocation. Patients should be made aware that it can cause anesthetic effects and may result in frostbite. It is crucial to avoid breathing the gas and to ensure adequate ventilation during its use. Patients should be instructed to keep oil and grease away from the gas and to use only equipment that has been cleaned for oxygen and is rated for cylinder pressure. They should also be cautioned against allowing liquid Nitrous Oxide to come into contact with their eyes, skin, or clothing. Additionally, the cylinder temperature should not exceed 52°C (125°F), and the valve should be opened slowly and closed after each use and when empty. A backflow preventive device should be utilized in the piping, and patients should follow the guidelines outlined in the Material Safety Data Sheet (MSDS).

In the event of an emergency, healthcare providers should instruct patients on first aid measures. If Nitrous Oxide is inhaled, patients should be removed to fresh air. If they are not breathing, artificial respiration should be administered. If breathing is difficult, oxygen should be provided, and a physician should be contacted. In cases of frostbite, immediate medical treatment is necessary.

Storage and Handling

The product is supplied in a cylinder format, which requires careful handling and storage to ensure safety and efficacy. It is essential to store the cylinder in an area with adequate ventilation to prevent the accumulation of potentially harmful gases.

The temperature of the cylinder must not exceed 52°C (125°F) during storage and use. When utilizing the product, the valve should be opened slowly to control the release of contents. After each use, and when the cylinder is empty, the valve must be securely closed to prevent any accidental discharge.

To maintain safety, a back flow preventive device should be installed in the piping system. Users are advised to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) for proper handling procedures. It is crucial to avoid contact with the liquid, ensuring that it does not come into contact with eyes, skin, or clothing. Additionally, all oil and grease should be kept away from the storage area to minimize the risk of fire or chemical reactions.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by Lessors, Incorporated. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)